| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$310 |
SEC Form S-1 Registration Statement
|
27 Nov 2025 9:09AM |
$5.810 |
$7.520 |
risen by
29.43%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris Technologies Global Corp. filed Form S-1 with the SEC.
- The registration covers 9,103,796 shares of Common Stock.
- Common Stock and CDI are listed under the symbol 'AVR'.
- Proceeds to be used primarily for DurAVR® THV system development.
- Company anticipates up to $40.4 million from warrant exercises.
- Company headquartered in Toowong, Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$386 |
Update - Notification of buy-back - RG8
|
27 Nov 2025 9:09AM |
$2.380 |
$2.630 |
risen by
10.50%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$114 |
Strategic Collaboration with JW Therapeutics
|
27 Nov 2025 9:08AM |
$0.325 |
$0.360 |
risen by
10.77%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene and JW Therapeutics enter strategic collaboration.
- Focus on combination therapy using onCARlytics and Carteyva®.
- Targets refractory solid tumors with a 'mark and kill' strategy.
- Preclinical studies and Phase 1 trial planned in China.
- Aims to validate onCARlytics platform with approved CAR-T product.
- Disciplined capital allocation and strategic flexibility ensured.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,731 |
Update - Notification of buy-back - RGN
|
27 Nov 2025 9:07AM |
$2.400 |
$2.365 |
fallen by
1.46%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$536 |
Update - Notification of buy-back - RG1
|
27 Nov 2025 9:07AM |
$1.970 |
$2.200 |
risen by
11.68%
|
|
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$3,008 |
Trading Halt
|
27 Nov 2025 9:07AM |
$7.600 |
$11.615 |
risen by
52.83%
|
|
SX2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Southern Cross Gold Consolidated Limited (SX2) requested a trading halt.
- The trading halt is pending an announcement about the Victorian Government's decision on a Work Plan application.
- The application concerns a tunnel development at Sunday Creek.
- The trading halt assists SX2 in managing continuous disclosure obligations.
- The halt will remain until normal trading on 1 December 2025 or upon release of the announcement.
- SX2 expects to announce details before the start of trading on 1 December 2025.
- The company sees no reason why the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Megaport Limited (MP1) ORDINARY FULLY PAID |
Information Technology |
$2,145 |
Megaport completes acquisition of Latitude.sh
|
27 Nov 2025 9:06AM |
$14.240 |
$12.080 |
fallen by
15.17%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,200 |
Update - Notification of buy-back - GYG
|
27 Nov 2025 9:05AM |
$22.870 |
$21.540 |
fallen by
5.82%
|
|
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$31 |
Update - Notification of buy-back - CDO
|
27 Nov 2025 9:05AM |
$1.810 |
$1.950 |
risen by
7.73%
|
|
| Encounter Resources Limited (ENR) ORDINARY FULLY PAID |
Materials |
$218 |
Annual General Meeting Presentation
|
27 Nov 2025 9:05AM |
$0.410 |
$0.390 |
fallen by
4.88%
|
|
| Latitude 66 Limited (LAT) ORDINARY FULLY PAID |
Materials |
$11 |
Laverton Gold Project Presentation
|
27 Nov 2025 9:03AM |
$0.055 |
$0.073 |
risen by
32.73%
|
|
| HUB24 Limited (HUB) ORDINARY FULLY PAID |
Financials |
$7,790 |
HUB24 Investor Strategy Day Presentation
|
27 Nov 2025 9:03AM |
$103.720 |
$95.260 |
fallen by
8.16%
|
|
HUB - Price-sensitive ASX Announcement
Full Release
Key Points
- HUB24's Investor Strategy Day presented growth and strategic initiatives.
- Focus on expanding market share in wealth management.
- Introduction of innovative solutions like myprosperity and Lifetime Retirement Solutions.
- Emphasis on enhancing adviser productivity through HUBconnect and myhub ecosystems.
- Continuous investment in technology and data solutions.
- Strong financial outlook with expanding UEBITDA margins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$25 |
Change of Director's Interest Notice - Steele
|
27 Nov 2025 9:01AM |
$0.070 |
$0.061 |
fallen by
12.86%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$45 |
Chair's Address to Shareholders
|
27 Nov 2025 9:00AM |
$0.430 |
$0.440 |
risen by
2.33%
|
|
IBC - Price-sensitive ASX Announcement
Full Release
Key Points
- Chairman Rob Lord addressed the AGM on 27 November 2025.
- Dividends increased by 6.4% to 2.5 cents per share.
- Portfolio returned 8.4%, underperforming the benchmark of 9.84%.
- Share buyback program was active but shares traded at a discount.
- Repositioning for income investors with quarterly dividends starting March 2026.
- Investment strategy focuses on diversified, defensive income generation.
- Challenges include inflation and low productivity.
- Company aims to address share mispricing compared to peers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liberty Financial Group (LFG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$1,257 |
Final Director's Interest Notice
|
27 Nov 2025 9:00AM |
$4.230 |
$4.140 |
fallen by
2.13%
|
|
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$22 |
Algorae Signs Distribution Agreement with Dr. Reddy's
|
27 Nov 2025 9:00AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Distribution agreement signed with Dr. Reddy’s Laboratories Ltd.
- First shipment of Capecitabine to Australia expected December 2025.
- Strategic partnership expands Algorae’s commercial footprint.
- Focus on oncology product commercialization.
- Executed two commercial agreements through AlgoraeRx Pty Ltd.
- Ongoing R&D activities at Peter MacCallum Cancer Centre.
- Positioning for long-term growth and future product collaborations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$494 |
Race Receives $2.8m RD Tax Refund
|
27 Nov 2025 8:59AM |
$2.900 |
$2.730 |
fallen by
5.86%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Race Oncology received a $2.8 million R&D Tax Refund.
- The refund is for the financial year ending 30 June 2025.
- It is part of the Australian government's R&D Tax Incentive program.
- An additional refund is expected in early 2026.
- Funds will support clinical development of RC220.
- RC220 targets include lung cancer and acute myeloid leukemia.
- The tax incentive offsets up to 43.5% of eligible R&D expenditure.
- Race Oncology is a Phase 3 clinical biopharmaceutical company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$212 |
Update - Notification of buy-back - CDM
|
27 Nov 2025 8:58AM |
$0.690 |
$0.710 |
risen by
2.90%
|
|
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$12 |
Lithium Anomalies and Pegmatites at Salinas South Project
|
27 Nov 2025 8:58AM |
$0.064 |
$0.063 |
fallen by
1.56%
|
|
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,158 |
Update - Notification of buy-back - DUI
|
27 Nov 2025 8:57AM |
$5.330 |
$5.400 |
risen by
1.31%
|
|
| Peel Mining Limited (PEX) ORDINARY FULLY PAID |
Materials |
$117 |
Nombinnie Exploration Update
|
27 Nov 2025 8:56AM |
$0.120 |
$0.140 |
risen by
16.67%
|
|
PEX - Price-sensitive ASX Announcement
Full Release
Key Points
- 20 RC drillholes with 2,706m completed at Nombinnie prospect.
- First 9 drillholes returned significant gold mineralization.
- NSW Government awarded $115,000 in exploration grants.
- High-grade intercept found in drillhole NBRC002.
- Exploration programs scheduled to continue into late 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$527 |
Update - Notification of buy-back - ACL
|
27 Nov 2025 8:56AM |
$2.900 |
$2.740 |
fallen by
5.52%
|
|
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$1,405 |
Update - Notification of buy-back - AUI
|
27 Nov 2025 8:55AM |
$11.040 |
$11.350 |
risen by
2.81%
|
|
| Iondrive Limited (ION) ORDINARY FULLY PAID |
Materials |
$53 |
CEO's Presentation to the Annual General Meeting
|
27 Nov 2025 8:55AM |
$0.050 |
$0.042 |
fallen by
16%
|
|
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$25 |
Investor Presentation - November 2025
|
27 Nov 2025 8:54AM |
$0.021 |
$0.022 |
risen by
4.76%
|
|